A Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-severe Systemic Disease Activity

NCT ID: NCT06104124

Last Updated: 2025-12-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

PHASE3

Total Enrollment

651 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-01-24

Study Completion Date

2026-08-19

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Primary Objective:

To evaluate the effect of dazodalibep on systemic manifestations of Sjögren's Syndrome (SS) in participants with moderate-to-severe systemic disease activity.

Secondary Objectives:

1. To evaluate the effect of dazodalibep on patient reported outcomes (PROs) in participants with SS.
2. To evaluate the safety and tolerability of dazodalibep in participants with SS

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Acquired from Horizon in 2024.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sjogren's Syndrome

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Sjögren's Syndrome With Moderate-to-severe Systemic Disease Activity Study Phase: Phase 3 European Alliance of Associations for Rheumatology Sjögren's Syndrome Disease Activity Index (ESSDAI) European Alliance of Associations for Rheumatology Sjögren's Syndrome Patient Reported Index (ESSPRI) European Alliance of Associations for Rheumatology (EULAR)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Dazodalibep Dose 1

Participants will be administered dose 1 of dazodalibep by intravenous (IV) infusion.

Group Type EXPERIMENTAL

Dazodalibep

Intervention Type DRUG

IV infusion

Dazodalibep Dose 2

Participants will be administered dose 2 of dazodalibep by IV infusion.

Group Type EXPERIMENTAL

Dazodalibep

Intervention Type DRUG

IV infusion

Placebo

Participants will be administered placebo by IV infusion.

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DRUG

IV infusion

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dazodalibep

IV infusion

Intervention Type DRUG

Placebo

IV infusion

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

VIB 4920 MEDI 4920

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosed with Sjögren's syndrome (SS) by meeting the 2016 American College of Rheumatology (ACR)/European Alliance of Associations for Rheumatology (EULAR) Classification Criteria.
* Have an European Alliance of Associations for Rheumatology Sjögren's Syndrome Disease Activity Index (ESSDAI) score of \>= 5 despite symptomatic or local therapy at screening.
* Positive for either anti-Ro autoantibodies or rheumatoid factor (RF), or both at screening (as per the central laboratory test).

Exclusion Criteria

* Medical history of confirmed deep vein thrombosis, pulmonary embolism, or arterial thromboembolism within 2 years of screening.
* Active malignancy or history of malignancy within the last 5 years, except in situ carcinoma of cervix treated with apparent success with curative therapy \> 12 months prior to screening OR cutaneous basal cell carcinoma following presumed curative therapy.
* Individuals with any severe or life-threatening cardiovascular (including vasculitis), respiratory, endocrine, gastrointestinal, hematological, psychiatric, or systemic disorder or any other condition that would place the individual at unacceptable risk of complications, interfere with evaluation of the IP, or confound the interpretation of participant safety or study results.
* Individuals who have a positive test for hepatitis B, hepatitis C, or HIV infection. A positive test for hepatitis B at screening is defined as: (1) positive for HBsAg OR (2) positive for either HBcAb or HBsAb and HBV DNA detected above the LLOQ by reflex testing by the central laboratory at screening.
* Active TB or untreated (per local guidelines) latent TB
* Individuals with a history of more than one episode of herpes zoster and/or any opportunistic infection in the last 12 months, and active infection requiring systemic treatment at the time of screening or through randomization, or history of more than 2 infections requiring intravenous (IV) antibiotics within 12 months prior to screening.
* Individuals who have received a live (attenuated) vaccine within the 4 weeks prior to randomization or plan to receive a live vaccine during their participation in the study.
* Last administration of experimental or investigational biologic or oral agents \< 6 months prior to screening.
* Individuals who have had previous treatment with any biologic B-cell-depleting therapy (eg, rituximab, ocrelizumab, inebilizumab, ofatumumab, or ianalumab) within 12 months or other B-cell-targeting therapy (eg, belimumab) \< 3 months prior to screening.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Amgen

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

MD

Role: STUDY_DIRECTOR

Amgen

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Arizona Arthritis & Rheumatology Associates - Avondale

Avondale, Arizona, United States

Site Status

Arizona Research Clinic PLLC

Chandler, Arizona, United States

Site Status

Arizona Arthritis and Rheumatology Associates - Flagstaff - 399 S Malpais Ln

Flagstaff, Arizona, United States

Site Status

Arizona Arthritis and Rheumatology Associates - Gilbert - 3645 S Rome St

Gilbert, Arizona, United States

Site Status

Arizona Arthritis and Rheumatology Associates - Glendale - 5681 W Beverly Ln

Glendale, Arizona, United States

Site Status

Arizona Arthritis and Rheumatology Associates - Tucson - 2001 W Orange Grove Rd

Tucson, Arizona, United States

Site Status

UCSD Altman Clinical and Translational Research Institute Building

La Jolla, California, United States

Site Status

Inland Rheumatology Clinical Trials Incorporated

Upland, California, United States

Site Status

Tekton Research, LLC - 2121 E Harmony Rd - PPDS

Fort Collins, Colorado, United States

Site Status

Bradenton Research Center Inc

Bradenton, Florida, United States

Site Status

Clinical Research of West Florida Inc - Clearwater

Clearwater, Florida, United States

Site Status

University of Miami - Leonard M. Miller School of Medicine

Miami, Florida, United States

Site Status

Suncoast Clinical Research - ATLAS - New Port Richey - PPDS

New Port Richey, Florida, United States

Site Status

Millennium Research

Ormond Beach, Florida, United States

Site Status

West Broward Rheumatology Associates, Inc.

Tamarac, Florida, United States

Site Status

BayCare Medical Group

Tampa, Florida, United States

Site Status

Augusta University Medical Center-Augusta-1120 15th St

Augusta, Georgia, United States

Site Status

OrthoIllinois, LTD

Rockford, Illinois, United States

Site Status

University of Kansas Medical Center

Kansas City, Kansas, United States

Site Status

Massachusetts General Hospital

Boston, Massachusetts, United States

Site Status

Clinical Research Institute of Michigan, LLC-St. Claire Shores

Saint Clair Shores, Michigan, United States

Site Status

Kansas City Physician Partners-8350 N Saint Clair Ave

Kansas City, Missouri, United States

Site Status

Arthritis, Rheumatic & Bone Disease Associates - P

Voorhees Township, New Jersey, United States

Site Status

NYU Langone Health - Joseph S. and Diane H. Steinberg Ambulatory Care Center

Brooklyn, New York, United States

Site Status

Arthritis and Osteoporosis Consultants of The Carolinas

Charlotte, North Carolina, United States

Site Status

Duke Early Phase Clinical Research Unit - PPDS

Durham, North Carolina, United States

Site Status

Onsite Clinical Solutions, LLC - Salisbury

Salisbury, North Carolina, United States

Site Status

Arthritis & Osteoporosis Center of Southwest Ohio - Miamisburg

Miamisburg, Ohio, United States

Site Status

University of Toledo Medical Center

Toledo, Ohio, United States

Site Status

STAT Research-600 Aviator Ct

Vandalia, Ohio, United States

Site Status

Low Country Rheumatology PA-Summerville

Summerville, South Carolina, United States

Site Status

Murfreesboro Medical Clinic Westlawn

Murfreesboro, Tennessee, United States

Site Status

Amarillo Center For Clinical Research

Amarillo, Texas, United States

Site Status

Tekton Research, LLC - W Gate Blvd - Austin - PPDS

Austin, Texas, United States

Site Status

Accurate Clinical Management-Baytown

Baytown, Texas, United States

Site Status

Precision Comprehensive Clinical Research Solutions

Grapevine, Texas, United States

Site Status

Prolato Clinical Research Center

Houston, Texas, United States

Site Status

R & H Clinical Research-777 S Fry Rd

Katy, Texas, United States

Site Status

Valley Arthritis Center

McAllen, Texas, United States

Site Status

University of Texas - San Antonio - Health Science Center - PPDS

San Antonio, Texas, United States

Site Status

DM Clinical Research - Migraine and COPD - PPDS

Tomball, Texas, United States

Site Status

Metrodora Institute

West Valley City, Utah, United States

Site Status

Overlake Arthritis & Osteoporosis Center

Bellevue, Washington, United States

Site Status

Western Washington Medical Group, Bothell - Rheumatology

Bothell, Washington, United States

Site Status

Rheumatology and Pulmonary Clinic

Beckley, West Virginia, United States

Site Status

Sanatorio Agote - Swiss Medical Group - PPDS

Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina

Site Status

Framingham Centro Médico

La Plata, Buenos Aires, Argentina

Site Status

Instituto CER S.A.

Quilmes, Buenos Aires, Argentina

Site Status

Instituto de Investigaciones Clinicas Quilmes SRL

Quilmes, Buenos Aires, Argentina

Site Status

MR Medicina Reumatologica

San Fernando, Buenos Aires, Argentina

Site Status

Hospital General de Agudos Dr. José María Ramos Mejia

Buenos Aires, Ciudad Autónoma de BuenosAires, Argentina

Site Status

Expertia S.A- Mautalén Salud e Investigación

Buenos Aires, Ciudad Autónoma de BuenosAires, Argentina

Site Status

Centro Privado de Medicina Familiar

Buenos Aires, Ciudad Autónoma de BuenosAires, Argentina

Site Status

Consultorios Médicos Dr. Doreski - Fundacion Respirar - PPDS

Buenos Aires, Ciudad Autónoma de BuenosAires, Argentina

Site Status

Sanatorio Allende S.A

Córdoba, Córdoba Province, Argentina

Site Status

Centro de Investigaciones Médicas Tucumán - PPDS

San Miguel de Tucumán, Tucumán Province, Argentina

Site Status

Centro de Investigaciones Reumatológicas

San Miguel de Tucumán, Tucumán Province, Argentina

Site Status

Clínica Mayo de U.M.C.B. S.R.L

San Miguel de Tucumán, Tucumán Province, Argentina

Site Status

DOM Centro de Reumatología

Buenos Aires, , Argentina

Site Status

Aprillus Asistencia e Investigacion de Arcis Salud SRL

Buenos Aires, , Argentina

Site Status

Centro Medico Arsema

Buenos Aires, , Argentina

Site Status

Centro Polivalente de Asistencia e Investigación Clínica - CER San Juan

San Juan, , Argentina

Site Status

The Queen Elizabeth Hospital

Woodville South, South Australia, Australia

Site Status

UZ Gent

Ghent, Oost-Vlaanderen, Belgium

Site Status

UZ Leuven

Leuven, Vlaams Brabant, Belgium

Site Status

SER - Serviços Especializados em Reumatologia da Bahia S/S - ME

Salvador, Estado de Bahia, Brazil

Site Status

AES - AS - L2IP - Instituto de Pesquisas Clínicas LTDA Brasilia

Brasília, Federal District, Brazil

Site Status

Irmandade da Santa Casa de Misericórdia de Belo Horizonte - PPDS

Belo Horizonte, Minas Gerais, Brazil

Site Status

Centro Mineiro de Pesquisa - CMiP

Juiz de Fora, Minas Gerais, Brazil

Site Status

Centro de Estudos em Terapias Inovadoras

Curitiba, Paraná, Brazil

Site Status

LMK Servicos Medicos SS

Porto Alegre, Rio Grande do Sul, Brazil

Site Status

Centre de Recherche Musculo-Squelettique - 1920 Rue Bellefeuille

Trois-Rivières, Quebec, Canada

Site Status

Clinical Research Chile SpA - PPDS

Valdivia, Los Ríos Region, Chile

Site Status

Centro de especialidades médicas Vanguardia

Temuco, Región de la Araucanía, Chile

Site Status

Centro de Investigacion de Enfermedades Respiratorias e inmunologicas

Viña del Mar, Región de Valparaíso, Chile

Site Status

Enroll SpA - Dr. Manuel Barros Borgono - PPDS

Providencia, Región-MetropolitanadeSantiago, Chile

Site Status

BIOCINETIC Ltda

Santiago, Región-MetropolitanadeSantiago, Chile

Site Status

Clinical Center Zagreb - Oncology - Salata 7 - PPDS

Zagreb, City of Zagreb, Croatia

Site Status

Polyclinic Bonifarm

Zagreb, City of Zagreb, Croatia

Site Status

Clinical Hospital Centre Osijek

Osijek, , Croatia

Site Status

University Hospital of Split-Spinciceva 1

Split, , Croatia

Site Status

Hopital Emile Muller

Mulhouse, Haut-Rhin, France

Site Status

CHU de Bordeaux - Hôpital Saint-André

Bordeaux, , France

Site Status

CHU de Brest - Hôpital La Cavale Blanche

Brest, , France

Site Status

AP-HP - Hôpital Bicêtre

Le Kremlin-Bicêtre, , France

Site Status

Hôpitaux Universitaires de Strasbourg

Strasbourg, , France

Site Status

Rheumazentrum Prof. Dr. med. Gunther Neeck-Standort Bad Doberan

Bad Doberan, Mecklenburg-Vorpommern, Germany

Site Status

Rheumazentrum Greifswald

Greifswald Hansestadt, Mecklenburg-Vorpommern, Germany

Site Status

DRK Gemeinnützige Krankenhaus GmbH Sachsen - DRK Krankenhaus Chemnitz-Rabenstein

Chemnitz, , Germany

Site Status

MVZ Rheuma

Hamburg, , Germany

Site Status

Olympion General Clinic

Kato Sychena Patras, Achaïa, Greece

Site Status

Naval Hospital of Athens

Athens, Attica, Greece

Site Status

Laiko General Hospital of Athens

Athens, Attica, Greece

Site Status

University General Hospital of Larissa

Larissa, Larisa, Greece

Site Status

Euromedica Kianous Stavros

Thessaloniki, , Greece

Site Status

Bekes Varmegyei Kozponti Korhaz

Gyula, Bekes County, Hungary

Site Status

Vasarhelyi Sarkanyfu Kft.

Hódmezővásárhely, Csongrád megye, Hungary

Site Status

Debreceni Egyetem Klinikai Kozpont Nagyerdei Campus

Debrecen, Hajdú-Bihar, Hungary

Site Status

Del-pesti Centrumkorhaz- Orszagos Hematologiai és Infektologiai Intezet - Albert Flórián út 5-7

Budapest, , Hungary

Site Status

Meir Medical Center

Kfar Saba, Central District, Israel

Site Status

The Chaim Sheba Medical Center - PPDS

Ramat Gan, , Israel

Site Status

AUSL di Reggio Emilia - IRCCS - Arcispedale Santa Maria Nuova

Reggio Emilia, Emilia-Romagna, Italy

Site Status

Azienda Sanitaria Universitaria Friuli Centrale - PO Universitario Santa Maria della Misericordia

Udine, Friuli Venezia Giulia, Italy

Site Status

Fondazione Policlinico Universitario Campus Bio-Medico

Rome, Lazio, Italy

Site Status

Fondazione Policlinico Universitario A Gemelli - Rome - PPDS

Rome, Lazio, Italy

Site Status

Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico

Milan, Lombardy, Italy

Site Status

A.O.U. Città della Salute e della Scienza di Torino

Turin, Piedmont, Italy

Site Status

AOU Policlinico Gaspare Rodolico-San Marco - Presidio Ospedaliero San Marco

Catania, Sicily, Italy

Site Status

Azienda Ospedaliera Universitaria Careggi

Florence, Tuscany, Italy

Site Status

Azienda Ospedaliero Universitaria Pisana - Stabilimento Santa Chiara

Pisa, Tuscany, Italy

Site Status

Azienda Ospedaliera Universitaria Integrata Di Verona

Verona, Veneto, Italy

Site Status

San Paolo Hospital Civitavecchia

Civitavecchia RM, , Italy

Site Status

Chubu Rosai Hospital

Nagoya, Aiti, Japan

Site Status

Japan Community Health Care Organization (JCHO) Chukyo Hospital

Nagoya, Aiti, Japan

Site Status

Daido Clinic

Nagoya, Aiti, Japan

Site Status

Sapporo Medical University Hospital

Sapporo, Hokkaidô, Japan

Site Status

Hokkaido University Hospital

Sapporo, Hokkaidô, Japan

Site Status

Hospital of the University of Occupational and Environmental Health, Japan

Kita Kyushu-shi, Hukuoka, Japan

Site Status

Hyogo Medical University Hospital

Nishinomiya-Shi, Hyôgo, Japan

Site Status

University of Tsukuba Hospital

Tsukuba, Ibaraki, Japan

Site Status

Kanazawa Medical University Hospital

Kahoku, Ishikawa-ken, Japan

Site Status

Kanazawa University Hospital

Kanazawa, Ishikawa-ken, Japan

Site Status

National Hospital Organization Yokohama Medical Center

Yokohama, Kanagawa, Japan

Site Status

University Hospital, Kyoto Prefectural University of Medicine

Kyoto, Kyôto, Japan

Site Status

Kyoto University Hospital

Kyoto, Kyôto, Japan

Site Status

Nagasaki University Hospital

Nagasaki, Nagasaki, Japan

Site Status

Sasebo Chuo Hospital

Sasebo-Shi, Nagasaki, Japan

Site Status

Kurashiki Medical Clinic

Kurashiki-Shi, Okayama-ken, Japan

Site Status

Saitama Medical University Hospital

Iruma-gun, Saitama, Japan

Site Status

Hamamatsu University Hospital

Hamamatsu, Shizuoka, Japan

Site Status

Nippon Medical School Hospital

Bunkyo-Ku, Tokyo, Japan

Site Status

St. Luke's International Hospital

Chuo-Ku, Tokyo, Japan

Site Status

Tokyo Medical Center

Meguro-Ku, Tokyo, Japan

Site Status

Keio University Hospital

Shinjuku-Ku, Tokyo, Japan

Site Status

Nihon University Itabashi Hospital

tabashi City, Tokyo, Japan

Site Status

Mediadvance Clinical S.A.P.I. de C.V.

Parques de San Felipe, Chihuahua, Mexico

Site Status

ONCOR - Centro de Infusion e Investigación Oncologia de Saltillo S.C

Saltillo, Coahuila, Mexico

Site Status

CIMAB SA de CV

Torreón Centro, Coahuila, Mexico

Site Status

Centro de Investigación en Artritis y Osteoporosis - PPDS

Mexicali, Estado de Baja California, Mexico

Site Status

Centro de Estudios de Investigacion Basica Y Clinica SC

Guadalajara, Jalisco, Mexico

Site Status

Bioclinica - Centro Integral En Reumatologia Sociedad Anónima de Capital Variable - PPDS

Guadalajara, Jalisco, Mexico

Site Status

Cryptex Investigación Clínica, S.A. de C.V.

Mexico City, Mexico City, Mexico

Site Status

Centro de Investigación y Tratamiento Reumatológico S.C

San Miguel Chapultepec, Mexico City, Mexico

Site Status

Unidad de Atencion Medica e Investigacion en Salud

Mérida, Yucatán, Mexico

Site Status

Centro de Investigacion Farmacologica Del Bajio Sc

León, , Mexico

Site Status

Consultorio de Reumatologia

México, , Mexico

Site Status

Clinstile, S.A. de C.V.

México, , Mexico

Site Status

Hospital Universitario Dr. Jose Eleuterio Gonzalez

Mitras Centro, , Mexico

Site Status

Accelerium, S. de R.L. de C.V. - PPDS

Monterrey, , Mexico

Site Status

Oaxaca Site Management Organization - Clinic - OSMO - PPDS

Oaxaca City, , Mexico

Site Status

Optimal Clinical Trials Ltd - PPDS

Auckland, , New Zealand

Site Status

Aotearoa Clinical Trials Trust

Auckland, , New Zealand

Site Status

Waikato Hospital

Hamilton, , New Zealand

Site Status

Clinica San Antonio S.A.C

Trujillo, La Libertad, Peru

Site Status

Clinica San Juan Bautista

San Juan de Lurigancho, Lima region, Peru

Site Status

Hogar Clinica San Juan de Dios - Arequipa

Arequipa, , Peru

Site Status

Hospital Militar Central Luis Arias Schereiber

Lima, , Peru

Site Status

Clínica Internacional San Borja-Avenida Guardia Civil 385

Lima, , Peru

Site Status

Instituto de Ginecologia y Reproduccion - PPDS

Lima, , Peru

Site Status

Alfredo Berrocal Kasay Reuma Sociedad de Responsabilidad Limitada

Pueblo Libre, , Peru

Site Status

Pratia Poznan - PPDS

Poznan, Greater Poland Voivodeship, Poland

Site Status

Med-Polonia Sp. z o.o.

Poznan, Greater Poland Voivodeship, Poland

Site Status

Prywatna Praktyka Lekarska Pawel Hrycaj

Poznan, Greater Poland Voivodeship, Poland

Site Status

Malopolskie Centrum Kliniczne

Krakow, Lesser Poland Voivodeship, Poland

Site Status

Centrum Medyczne Oporow

Wroclaw, Lower Silesian Voivodeship, Poland

Site Status

Dolnoslaski Szpital Specjalistyczny im. T. Marciniaka, Centrum Medycyny Ratunkowej

Wroclaw, Lower Silesian Voivodeship, Poland

Site Status

ETG Lublin - PPDS

Lublin, Lublin Voivodeship, Poland

Site Status

Reumed Sp. z o.o.

Lublin, Lublin Voivodeship, Poland

Site Status

FutureMeds - Warszawa Centrum - PPDS

Warsaw, Masovian Voivodeship, Poland

Site Status

MICS Centrum Medyczne Warszawa - MICS - PPDS

Warsaw, Masovian Voivodeship, Poland

Site Status

MTZ Clinical Research Powered by PRATIA - PPDS

Warsaw, Masovian Voivodeship, Poland

Site Status

Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji im. Prof. Dr hab. Med. Eleonory Reicher

Warsaw, Masovian Voivodeship, Poland

Site Status

Klinika Reuma Park sp . zoo Sp.k.

Warsaw, Masovian Voivodeship, Poland

Site Status

FutureMeds - Targowek - PPDS

Warsaw, Masovian Voivodeship, Poland

Site Status

K2J2 Medical Center

Wołomin, Masovian Voivodeship, Poland

Site Status

Centrum Badawcze Panaceum Agnieszka Brzezicka Magdalena Lenkiewicz Sp. Z o.o.

Malbork, Pomeranian Voivodeship, Poland

Site Status

MICS Centrum Medyczne Bydgoszcz

Bydgoszcz, , Poland

Site Status

Szpital Uniwersytecki Nr 2 im. Dr Jana Biziela w Bydgoszczy

Bydgoszcz, , Poland

Site Status

Centrum Medyczne Pratia Katowice - PPDS

Katowice, , Poland

Site Status

Centrum Medyczne Plejady Magdalena Celinska - Lowenhoff, Michal Zolnowski Spolka komandytowa

Krakow, , Poland

Site Status

Centrum Medyczne PROMED- Olszanska 5G

Krakow, , Poland

Site Status

FutureMeds - Lodz - PPDS

Lodz, , Poland

Site Status

Twoja Przychodnia PCM

Poznan, , Poland

Site Status

ETG Warszawa - PPDS

Warsaw, , Poland

Site Status

WIM-PIB, Centralny Szpital Kliniczny MON

Warsaw, , Poland

Site Status

Uniwersytecki Szpital Kliniczny im. Jana Mikulicza Radeckiego we Wroclawiu - Borowska 213

Wroclaw, , Poland

Site Status

Pracownia Badan Klinicznych Salus - ul. Ołtaszyńska 92c/3

Wroclaw, , Poland

Site Status

FutureMeds - Wroclaw - PPDS

Wroclaw, , Poland

Site Status

ULS de Lisboa Ocidental, EPE - Hospital Egas Moniz

Lisbon, Lisbon District, Portugal

Site Status

Hospital Conde de Bertiandos - Unidade Local de saúde do Alto Minho, EPE - Ponte de Lima

Ponte de Lima, Viana do Castelo District, Portugal

Site Status

Centro Hospitalar Universitário Lisboa Norte, E.P.E - PPDS

Lisbon, , Portugal

Site Status

ULS de Gaia/Espinho, EPE - Unidade I

Vila Nova de Gaia, , Portugal

Site Status

GCM Medical Group, PSC -62 Calle Jose Marti

San Juan, , Puerto Rico

Site Status

Institute of Rheumatology - PPDS

Belgrade, , Serbia

Site Status

Military Medical Academy

Belgrade, , Serbia

Site Status

University Clinical Center of Serbia - Pasterova 2 - PPDS

Belgrade, , Serbia

Site Status

University Clinical Center Kragujevac

Kragujevac, , Serbia

Site Status

Clinical Centre of Vojvodina

Novi Sad, , Serbia

Site Status

Special Hospital For Rheumatic Diseases Novi Sad

Novi Sad, , Serbia

Site Status

The Catholic University of Korea, Seoul St. Mary's Hospital

Seoul, , South Korea

Site Status

C.H. Regional Reina Sofia - PPDS

Córdoba, Córdoba, Spain

Site Status

Hospital Regional Universitario de Malaga - Hospital Civil

Málaga, Málaga, Spain

Site Status

Hospital Universitario de Basurto

Bilbao, , Spain

Site Status

Hospital Universitario Infanta Leonor

Madrid, , Spain

Site Status

Hospital Universitario 12 de Octubre

Madrid, , Spain

Site Status

Fundacio Hospital de l'Esperit Sant

Santa Coloma de Gramenet(Barcelona), , Spain

Site Status

Hospital Universitario de Canarias

Santa Cruz de Tenerife, , Spain

Site Status

Hospital Quironsalud Infanta Luisa

Seville, , Spain

Site Status

Hospital Nuestra Señora de Valme

Seville, , Spain

Site Status

Chang Gung Memorial Hospital, Linkou

Gui Shan Qu, , Taiwan

Site Status

Kaohsiung Medical University - Chung-Ho Memorial Hospital

Kaohsiung City, , Taiwan

Site Status

Taichung Veterans General Hospital

Taichung, , Taiwan

Site Status

Taipei Medical University Hospital - PPDS

Taipei, , Taiwan

Site Status

Chapel Allerton Hospital - PPDS

Leeds, , United Kingdom

Site Status

William Harvey Research Institute - PPDS

London, , United Kingdom

Site Status

Royal Victoria Infirmary

Newcastle upon Tyne, , United Kingdom

Site Status

Queen Alexandra Hospital

Portsmouth, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Denmark Slovenia United States Argentina Australia Belgium Brazil Canada Chile Croatia France Germany Greece Hungary Israel Italy Japan Mexico New Zealand Peru Poland Portugal Puerto Rico Serbia South Korea Spain Taiwan United Kingdom

Related Links

Access external resources that provide additional context or updates about the study.

http://www.amgentrials.com

AmgenTrials clinical trials website

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2023-503904-10-00

Identifier Type: REGISTRY

Identifier Source: secondary_id

HZNP-DAZ-301

Identifier Type: -

Identifier Source: org_study_id